Sectors

SNGX
Soligenix, Inc.
0.36
66 x 0.36
2 x 0.36
bid
ask
-
0.01
1.81%
01:38 PM
timesize
Ytd-73.32%
1y-74.65%
0.35
day range
0.37
0.28
52 week range
6.23
Open0.36Prev Close0.36Low0.35High0.37Mkt Cap3.75M
Vol203.31KAvg Vol7.58MEPS-1.36P/E-0.27Forward P/E-0.56
Beta1.92Short Ratio1.06Inst. Own2.63%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg0.44200-d Avg1.081yr Est22.50

SNGX News

From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
feeds.newsfilecorp.com
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co

Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
prnewswire.com
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Thermostability, immunogenicity and efficacy data against related viruses provides firm starting poi

benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results
benzinga.com
Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results

U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results
benzinga.com
Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results

US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en

Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
prnewswire.com
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo

Thermostability, immunogenicity and efficacy data against related virusesmay provide rapid starting

Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
prnewswire.com
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compan

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Crude Oil Gains Over 3%; General Motors Earnings Top Views
benzinga.com
Crude Oil Gains Over 3%; General Motors Earnings Top Views

US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0

Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings
benzinga.com
Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings

US stocks mixed with Dow up 150 pts. Dow up 0.27%, NASDAQ down 1.06%, S&P 500 down 0.52%. Energy

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
prnewswire.com
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment o

PRINCETON, N.J., April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
prnewswire.com
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in t

HyBryte™ demonstrates more rapid and robust treatment response compared toValchlor ® during 12-week

Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
prnewswire.com
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

Upcoming high-impact milestones include interim analysis in Q2 2026 and top-line results in H2 2026

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
prnewswire.com
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment

PRINCETON, N.J., March 26, 2026 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
prnewswire.com
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Highlighting Positive Results in Comparison to Valchlor ® and in Real-World Use PRINCETON, N.J., Mar

IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
globenewswire.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schab

AUSTIN, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organ

Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
prnewswire.com
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"

PRINCETON, N.J., March 19, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
prnewswire.com
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines

PRINCETON, N.J., March 10, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
prnewswire.com
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Dru

PRINCETON, N.J., Feb. 26, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

Soligenix to Present at BIO Investment & Growth Summit
prnewswire.com
Soligenix to Present at BIO Investment & Growth Summit

PRINCETON, N.J., Feb. 24, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

Soligenix Details Recent Progress and Upcoming Milestones
prnewswire.com
Soligenix Details Recent Progress and Upcoming Milestones

PRINCETON, N.J., Feb. 12, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

Short Interest in Soligenix Inc. (NASDAQ:SNGX) Decreases By 12.5%
defenseworld.net
Short Interest in Soligenix Inc. (NASDAQ:SNGX) Decreases By 12.5%

Soligenix Inc. (NASDAQ: SNGX - Get Free Report) was the target of a significant drop in short intere

Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)
prnewswire.com
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Publish

Study results support advancing SGX945 in this difficult-to-treat orphan disease Results suggest pot

Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel
benzinga.com
Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel

Soligenix, Inc. (NASDAQ: SNGX) on Wednesday announced extended results of its ongoing Phase 2a trial

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis
prnewswire.com
Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patien

Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J.

Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
globenewswire.com
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Spac

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- via BioMedWire: — Soligenix Inc. (NASDAQ: SNGX) today an

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  Thursday's session saw 189 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Friday

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Thursday